Lambda Canada | lambdanews
archive,paged,category,category-lambdanews,category-36,paged-2,category-paged-2,ajax_fade,page_not_loaded,,qode-theme-ver-3.6,wpb-js-composer js-comp-ver-5.2,vc_responsive


Drugs and Health Products

  |   lambdanews   |   No comment

The purpose of this notice is to clarify Health Canada’s interpretation and expectations for all matrix-based stability experiments [that is (i.e.) Long term, Freeze-thaw and Bench top] conducted during bioanalytical method validation.   It has come to the attention of Health Canada that some companies conducting the...

Read More